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Summary
AIMS OF THE STUDY: To investigate the computed to-
mography (CT) density of frequently administered med-
ications (1) for the better characterisation of substances
on abdominal CT, (2) to allow radiologists to narrow down
possibilities in the identification of hyperdense material in
the bowel and (3) to provide forensic doctors with a tool to
identify gastric contents before an autopsy.
MATERIAL AND METHODS: From the list of the local
hospital pharmacy, the 50 most frequently used medica-
tions were identified and scanned twice with a 128 row CT
scanner (Acquillion, Toshiba, Tokyo, Japan). The protocol
comprised two tube voltages of 100 kVp and 120 kVp, with
a tube current of 100 mAs, a collimation of 0.5 mm and
a slice thickness of 0.5 mm. Two readers were asked to
measure the density (in Hounsfield units) and the noise
(standard deviation of the Hounsfield units) of each pill in
the two scans (100/120 kVp). After 4 weeks, both read-
ers repeated the measurements to test repeatability (intra-
rater agreement). The behaviour of each pill in hydrochlo-
ric acid (pH 2) was examined and the dissolution time was
determined.
RESULTS: The most dense pill was Cordarone (7265
HU), and the least was Perenterol (−529 HU), with an at-
tenuation that was lower than fat density (<−120 HU). The
standard deviation of pixel density (noise) reflects inhomo-
geneity of the pharmacological product, varying from 9 to
1592 HU among the different pills (at 120 kVp). The ab-
solute average HU increase per pill when changing to low-
er voltage was 78 ± 253 HU, with a linear fitting line with
a slope of 0.21 as a constant variable in the density spec-
troscopy. After 4 hours in hydrochloric acid, only six tablets
were still intact, including Flagyl and Dafalgan. The in-
tra- and inter-rater agreements for all measurements were
nearly perfect, with a correlation coefficient r of ≥0.99 (p
<0.0001).
CONCLUSION: Our data suggest that measuring the at-
tenuation of drugs on CT images, including the homo-
geneity, and applying CT spectroscopy can narrow down
possible identities of the most frequently medications. Oth-
er clinicians and forensic pathologists can perform this
easy measurement, as the intra- and inter-reader variabil-
ity is very small.
Key words: computed tomography imaging, characterisa-
tion of drugs in CT, radiation density measurements, CT
spectroscopy
Introduction
Radiologists routinely encounter various radiopaque struc-
tures within the gastrointestinal tract, including pills or for-
eign bodies [1, 2]. The first medications to have their ra-
diopaque characteristics identified were iron preparations,
which were studied in vivo and in vitro with standard ra-
diography in the era before the invention of computed to-
mography [3]. Various radiodensities were found for dif-
ferent pills on conventional radiographs. However, two
thirds of all pills are not detectable with radiography, main-
ly because of their dissolution within the gastric lumen [4].
With advances in CT imaging, the detection of radiopaque
drugs within the bowel lumen has increased substantially
[5]. Pills with densities below 900 Hounsfield units (HU)
are not visible on standard abdominal radiographs, but be-
come apparent with the superior resolution of CT. Most of
the selected drugs differed in density, depending on their
excipients, size and shape. During the radiological assess-
ment of a substance within the gastrointestinal tract, the
CHIPES mnemonic is used [1], this is an acronym of chlo-
ral hydrate, heavy metals, iron, psychotropics and enteric-
coated and sustained-release preparations.
In patients undergoing an abdominal CT scan, a density
assessment of pills incidentally found within the gastroin-
testinal tract might provide additional information on ap-
propriate therapy (compliance) and might even be life-
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saving, especially in unconscious and non-communicative
patients. Furthermore, identification and classification of
pills found on post-mortem CTs could be important in de-
termining the cause of death [6].
CT spectroscopy offers the opportunity to classify ra-
diopaque material. At different levels of CT tube voltages,
the assessed material changes attenuation. For each ma-
terial, depending on the dominant substance, there is a
specific change in X-ray absorption [7]. From the density
change at different voltage levels, one can conclude which
substances were scanned. Therefore, CT spectroscopy has
found its way into clinical applications. For example, it
can be used to differentiate between gout (urate deposition)
and pseudogout (calcium pyrophosphate deposition) [8].
The characterisation of renal stones is also feasible with
dual-energy CT and is crucial for therapeutic management
[9, 10]. Therefore, CT spectroscopy could hypothetically
aid in characterising active and passive agents in orally ad-
ministered drugs.
The purpose of this study was to investigate the CT density
of frequently administered medications (1) for the better
characterisation of substances on abdominal CT, (2) to al-
low radiologists to narrow down possibilities in the iden-
tification of hyperdense material in the bowel and (3) to
provide forensic doctors with a tool to identify gastric con-
tent before an autopsy. The additional value of CT spec-
troscopy in the medication identification process was also
analysed.
Materials and methods
Approval of the ethics committee was waived because no
humans were involved in this phantom study.
Data acquisition
From the list of the local hospital pharmacy, the 50 most
frequently used medications were identified. The cut-off
was more than 1000 original units used in the year 2015.
Medications in non-tablet form were not included because
their HU changes rapidly in the stomach. Of the 50 med-
ications, 4 were excluded because they were fizzy or liq-
uid.
Experiment 1
The remaining 46 products were taped to the back of card-
board kidney basins (fig. 1). Neither the tape nor the basins
had significant radiodensity.
The cardboard was scanned with a 128 row CT scanner
(Acquillion, Toshiba, Tokyo, Japan). To the standard rou-
tine abdominal CT protocol with a tube voltages of 120
kVp, an additional scan with 100 kVp was added to per-
Figure 1: (a) Sagittal reconstruction of scan layout with dens pills
attached to cardboard kidney basins and (b) coronal close up of
different examples of drugs, with obvious attenuation differences.
form CT spectroscopy. A constant tube current of 150 mAs
was used, with detector rows of 0.5 × 64. Pitch factor
PF 0.828/helical pitch HP 53 was used and rotation time
was fixed to 1 rotation per second. Standard medium scan
and display field of view (32 cm, M320) was consistently
used. Images were reconstructed with the standard abdom-
inal kernel FC07 and the iterative reconstruction
AIDR_3D_Standard. A collimation of 0.5 mm, a slice
thickness of 0.5 mm and an increment of 0.3 mm were
used.
The tablets were scanned along the longest diameter in the
axial plane.
Experiment 2
The experiment was repeated with the same scan protocol
and the pills submerged in hydrochloric acid. All available
medicaments were examined in separate plastic cups (25
ml). The cups were taped to cardboard in a linear fashion,
such that only one pill appeared on axial CT scans (fig. 2).
Of the original 46 medicaments, 4 were no longer avail-
able owing to changes of suppliers to the hospital phar-
macy (Mirtazapin, Novalgin, Torem and Perindopril). Ac-
cording to the literature, average gastric juice is equivalent
to hydrochloric acid with pH between 2 and 3 [11]. Hy-
drochloric acid at a concentration of 0.01 mol/l (pH 2) was
poured into the cups at time t = 0. The scans were repeated
at t = 5, 10, 15, 30 and 60 minutes and 2, 4, 8, 12, 16, 24,
36, 48, 72, 96 hours. The CT scans were performed with
100 and 120 kV at each time-point.
Read-out
Experiment 1
The read-out was performed on a GE-Workstation (Gener-
al Electric, Milwaukee, WI, USA) by two readers. A cir-
cular region of interest (ROI) was placed in the middle of
each tablet with the largest diameter possible, without en-
closing the air around the tablet. When the tablet had a
coating with density different from the large core, the coat-
ing was not included in the measurement (fig. 3).
The readers made all measurements separately and were
unaware of the drug identities.
Reader 1 was a staff radiologist with 5 years of CT imaging
experience, and reader 2 was a specialist in internal medi-
Figure 2: Pre-scan CT-scout of the 50 plastic cups (view from
above). (a) 5 minute after submerging the pills into hydrochloric
acid. (b) 30 minutes after submerging the pills. The white arrow
point towards the stable potassium pill (KCl Retard) and the black
arrow demonstrates the decay of Cordarone.
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cine with 7 years of clinical experience, including CT read-
ing without specific radiological training.
The readers undertook two read-out sessions. In the first,
they measured the density and noise (standard deviation
[SD] of pixel density in the ROI) of each pill in the two
scans (100/120 kVp). After a break of 4 weeks, the readers
repeated the measurements to test repeatability (intra-rater
agreement).
Experiment 2
The density of the pills was measured by one radiologist
(reader 1) and the Hounsfield units (HU) and the SD were
recorded. Decomposition/dissolution of the pills was de-
fined as a permanent density drop of the HU under the
original HU score minus double the SD of the readers. For
drugs with a negative original HU, the cut-off value for
dissolution was the original HU plus double the SD (nor-
mal HU of water/acid is 0 HU). CT spectroscopy is valid
only as long as the pills are intact.
Statistics
For every ROI, the mean pixel density (in HU) and the
SD of pixel densities (noise) were noted during the read-
out. The standard deviation of the four HU measurements
of the same pill at the same tube voltage and the average
HU for the two readers for each pill at both voltage levels
were then calculated. The inter- and intra-rater agreements
were calculated from the correlation coefficients of the two
readers. The CT spectroscopic changes in pill density at
the two different tube voltages were calculated as both ab-
solute and relative (delta HU divided by the HU at the 120
kVp level) values. The delta HU was plotted against the
pill density at the 120 kVp level, a linear trend line was fit-
ted and the formula was calculated.
Results
Experiment 1
The mean density for the pills was 525 ± 100 HU at 120
kVp and increased to 603 ± 81 at the lower 100 kVp level
(p <0.0001).
The mean density of all pills at both tube voltage levels, in-
cluding their standard deviations, are listed in table 1. The
most dense pill was Cordarone, and the least dense was
Perenterol, with an attenuation that was lower than the den-
sity of fat (<−120 HU).
The standard deviation of pixel density in the ROI (noise)
reflects inhomogeneity of the pharmacological product.
Figure 3: Co-Amoxicillin Sandoz 1 g at 100 kV with a density 6.6
Hounsfield Units.
These indirect signs of homogeneity varied from 9 to 1592
HU among the different pills (at 120 kVp). On average,
noise scored 100 ± 236 HU.
The absolute average HU increase per pill when changing
to the lower voltage was 78 ± 253 HU. When this absolute
density was standardised to the original 120 kVp density
(delta HU/120 kVp HU), the average relative density in-
crease was 13.8 ± 61%. Only 30 of the 46 pills showed an
increase in density when the voltage was decreased. Fif-
teen pills demonstrated a density decrease, whereas one
pill had no density change, leading to a linear fitting line
with a slope of 0.21 as a constant variable in the density
spectroscopy (fig. 4). The ranking of the relative density
change is given in table 2. The density of Eltroxin did not
change and stayed at 252 HU. All of the medications that
are listed above Eltroxin demonstrated an increased densi-
ty for lower voltages. The medications listed below Eltrox-
in showed a decrease in density (table 2).
Experiment 2
The HU and CT spectroscopy values are valid only as
long as the pills are not dissolved (in hydrochloric acid).
In addition to disintegration of the HU, a dissolving pill
had blurred margins and loss of shape and contour (fig.
5). Each pill’s individual duration of integrity is marked in
green in table S1 (appendix 1, available in a separate file
for downloading); the red fields indicate the time when the
pills were first dissolved. Twenty-one medicaments had al-
ready dissolved after 5 minutes in hydrochloric acid and
another 10 after 30 minutes; 11 pills were intact for 2
hours or longer (up to 4 days, table S1). HU values from
both scans at 100 kVp (table S2) and 120 kVp are re-
ported for the entire duration of the experiment, since CT
spectroscopy of pill sedimentation can theoretically still be
used after decomposition (in a laboratory environment and
without bowel movements).
Rater agreement
The agreement between readers for all measurements of
experiment 1 was almost perfect, with a correlation co-
efficient r of 0.9902 (95% confidence interval [CI]
0.9869–0.9927; p <0.0001). The intra-reader variability
was very low, with a correlation coefficient r of 0.9986
(95% CI 0.9979–0.9991; p <0.0001) for reader 1 and r =
0.9895 (95% CI 0.9842–0.9931; p <0.0001) for reader 2.
Figure 4: Spectroscopic increase of HU at lower tube voltage.
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Discussion
The aim of the study was to report the density of selected
drugs and provide a reference for radiologists in their
everyday practice. Our results showed that each of the se-
lected drugs had different X-ray absorption, thus facilitat-
ing their assessment in the gastrointestinal tract. These dif-
ferences result in differences in image densities, which, in
addition to their size and shape, should allow the differen-
tiation of medicines from other potential foreign bodies in
the gastrointestinal tract, e.g., stones [12–14] and bezoars
[15–18]. The pills could easily be measured on abdominal
CT images and could be compared with the attenuation and
noise of typical medications, as listed in table 1, to narrow
down the possible identity of the agent.
The high inter- and intra-rater agreements, with an almost
perfect correlation, confirm the good repeatability, and this
method is suitable for use by radiologically untrained
physicians. Any clinician can look at routine CT images
and determine if the correct pill was taken, another pill was
taken, or too many pills were taken (compliance). The time
of decomposition of each pill is an important variable for
identifying medicaments within the human body. For in-
stance, Nexium MUPS 40 mg decomposed within 5 min-
utes and can be generally excluded when an intact pill is
detected in the small bowel. The same applied for many
Table 1: Medicaments ranked according to density at 120 kV.
HU
100 kV
SD ROI
(noise)
SD Readers HU
120 kV
SD ROI
(noise)
SD Readers Difference HU Relative delta (to
original HU at 120 kV)
Cordarone Tabl 200 mg 8894 1664 931 7265 1592 441 1629 0.224
KCL Retard Hausmann Drag 3390 242 81 2829 218 46 561 0.198
Concor Lacktabl 5 mg 2043 643 491 1879 485 265 163 0.087
Aldactone Filmtabl 25 mg 1603 229 211 1358 182 101 245 0.180
Lisinopril Tabl 20 mg 1271 200 155 1145 117 106 126 0.110
Januvia Filmtabl 50 mg 984 149 172 899 82 33 84 0.094
Trittico Tabl 50 mg 779 86 32 728 77 25 51 0.070
Benerva Tabl 300 mg 772 90 9 638 35 12 134 0.209
Amlodipin Tabl 10 mg Spirig HC 548 60 47 555 68 50 −7 −0.012
Atorvastatin Filmtabl 40 mg 607 35 24 524 31 21 82 0.157
Benexol B12 Tabl 522 118 43 427 94 55 94 0.221
Brilique Filmtabl 90 mg 472 34 25 419 26 20 54 0.128
Metformin Lactabs 1000 mg 470 12 1 377 9 2 92 0.244
Citalopram 20 mg 476 61 88 355 126 101 121 0.339
Plavix Tabl 75 mg 378 47 14 333 36 11 45 0.137
Novalgin Tabl 500 mg 371 26 8 318 50 13 53 0.166
Crestor Filmtabl 10 mg 332 35 32 310 13 28 22 0.071
Acidum Folicum Streuli Tabl 5 mg 260 11 19 305 36 20 −45 −0.147
Phoscap Kaps 250 339 115 68 297 99 54 43 0.144
Becozym Drag forte 312 37 5 292 51 28 21 0.071
Prednison Streuli Tabl 5 mg 196 119 112 269 16 22 −73 −0.271
Marcoumar Tabl 3 mg 257 59 92 258 119 63 −1 −0.004
Eltroxin−LF Tabl 0.1 mg 252 8 24 252 29 30 0 0.000
Candesartan Tabl 16 mg 250 6 16 250 23 23 0 0.001
Dipiperon Tabl 277 24 27 227 20 35 50 0.220
Quetiapin Filmtabl 25 mg 253 82 34 222 45 28 31 0.138
Simvastatin Filmtabl 40 mg 229 38 22 221 48 19 9 0.040
Aspirin Cardio 100 Filmtabl 100 mg 186 41 48 216 11 13 −30 −0.138
Valverde Schlaf Filmtabl 197 22 5 199 21 17 −1 −0.007
Nebivolol Tabl 5 mg 236 47 90 186 99 49 51 0.273
Primperan Tabl 10 mg 44 114 213 181 32 23 −137 −0.758
Mirtazapin Filmtabl 30 mg 193 20 18 177 38 29 16 0.090
Flagyl Tabl 500 mg 153 18 7 161 14 6 −8 −0.048
Zolpidem Filmtabl 10 mg 103 98 215 144 82 151 −41 −0.283
Beloc Zok 100 Ret Tabl 100 mg 104 43 42 139 23 6 −35 −0.251
Pantozol Tabl 20 mg 163 59 51 134 82 61 29 0.216
Madopar LIQ Tabl 62.5 mg 134 67 42 131 68 51 2 0.017
Neo Mercazole Tabl 5 mg 114 27 23 105 21 20 9 0.081
Nexium MUPS 40 Tabl 40 mg 77 25 5 59 22 8 18 0.304
Torem 10 Tabl 10 mg 256 52 36 55 78 214 201 3.640
Dafalgan Filmtabl 1 g 30 13 3 45 11 6 −15 −0.334
Co-Amoxicillin Sandoz Disp Tabl 1 g 6 8 1 −10 8 4 15 1.572
Irfen 400 Lactabs 400 mg −26 16 17 −20 20 10 −6 −0.287
Tamsulosin eco Ret Kaps 0.4 mg −93 15 6 −93 15 9 −1 −0.008
Perindopril Sandoz Tabl 4 mg −146 97 27 −96 74 43 −50 −0.524
Perenterol Kaps 250 mg −550 152 106 −529 138 63 −21 −0.040
HU = Hounsfield units; ROI = region of interest; SD = standard deviation
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medicaments, and some dissolved over hours; Flagyl 500
mg or Dafalgan 1g were still intact at the end of the ex-
periment (after 4 days). These latter medicaments are de-
signed to dissolve in the small intestine, have an anti-acid
protective coating, and would probably dissolve faster in
pH >7 (bile). HU of both scans for 100 and 120 kVp are
reported for the entire duration of the experiment, since CT
spectroscopy of pill sedimentation can theoretically still be
used after decomposition (in a laboratory environment and
without bowel movements).
The proposed characterisation aimed to facilitate better di-
agnostics and interpretation of radiological results, lead-
ing to better patient treatment. Another important aspect is
the qualitative and quantitative assessment of drugs in pa-
tients who have attempted or completed suicide. No-one
would routinely perform an additional scan to calculate the
spectroscopic behaviour of the ingested pills, but in post-
mortem CT studies [19] the radiation dose is less impor-
tant and a scan could help identify the ingested substance
prior to autopsy. Post-mortem imaging might help narrow
down the possible causes of death. Aghayev et al. demon-
Table 2: Medicaments with negative delta (lower HU with lower kV [tube voltage]).
HU
100 kV
SD ROI (noise) SD Readers HU
120 kV
SD ROI
(noise)
SD Readers Difference HU Relative delta (to
original HU at 120
kV)
Primperan Tabl 10 mg 44 114 213 181 32 23 −137 −0.758
Prednison Streuli Tabl 5 mg 196 119 112 269 16 22 −73 −0.271
Perindopril Sandoz Tabl 4 mg −146 97 27 −96 74 43 −50 −0.524
Acidum Folicum Streuli Tabl 5 mg 260 11 19 305 36 20 −45 −0.147
Zolpidem Filmtabl 10 mg 103 98 215 144 82 151 −41 −0.283
Beloc Zok 100 Ret Tabl 100 mg 104 43 42 139 23 6 −35 −0.251
Aspirin Cardio 100 Filmtabl 100 mg 186 41 48 216 11 13 −30 −0.138
Perenterol Kaps 250 mg −550 152 106 −529 138 63 −21 −0.040
Dafalgan Filmtabl 1 g 30 13 3 45 11 6 −15 −0.334
Flagyl Tabl 500 mg 153 18 7 161 14 6 −8 −0.048
Amlodipin Tabl 10 mg Spirig HC 548 60 47 555 68 50 −7 −0.012
Irfen 400 Lactabs 400 mg −26 16 17 −20 20 10 −6 −0.287
Valverde Schlaf Filmtabl 197 22 5 199 21 17 −1 −0.007
Marcoumar Tabl 3 mg 257 59 92 258 119 63 −1 −0.004
Tamsulosin eco Ret Kaps 0.4 mg −93 15 6 −93 15 9 −1 −0.008
Eltroxin−LF Tabl 0.1 mg 252 8 24 252 29 30 0 0.000
Candesartan Tabl 16 mg 250 6 16 250 23 23 0 0.001
HU = Hounsfield units; ROI = region of interest; SD = standard deviation
Figure 5: Dissolution process of medicaments in hydrochloric acid (pH 2): Co-Amoxicillin was already dissolved after 5 min (note the small
black air bubbles during the decay). Neo Mecazole was still intact after 5 min and dissolved after 15 min. Metformin demonstrated the same
shape and density over 60 min and was dissolving after 4 hours. Note the hyperdense liquid in the cup at 8 hours.
Original article Swiss Med Wkly. 2018;148:w14585
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 5 of 7
strated hyperattenuating gastric content in cases of suicide
by medication intoxication, with densities from 88 to 338
HU as the pills were dissolving.
The phantom technique that was used to identify the com-
position of substances is often used in diagnostic radiology
because it ties together the study environment and the hu-
man environment without harmful radiation exposure. Us-
ing a CT scanner with dose optimisation, one abdominal
CT spiral exposes patients to an average radiation dose
below 200 mGycm; after the weighting factor for the ab-
domen is applied this gives an average equivalent dose of
2mSv for low dose CT [20]. The risk of cancer death due
to this scan / radiation dose is 1:10 000 [21]. Maybe in fu-
ture, with steady technical improvement, an ultra-low dose
CT scan can be used for comprehensive compliance mea-
surement.
However, these results should be interpreted in light of
several limitations. The medicaments were examined only
in air and a simulated gastric acid milieu. Depending on
the gastric passage time, the pills would come into contact
with alkaline bile and pancreatic enzymes, which could al-
ter the decomposition time. Further experiments need to
address the decomposition of medicaments in a changing
environment. We did not assess the influence of tempera-
ture and bowel movements, which could have a direct im-
pact on the pill’s macroscopic and chemical structure, and
could thus change its density. During the assessment, the
patients’ individual differences must also be considered,
e.g., hyper- or hypoacidity, interaction with other drugs, or
other physical and chemical factors that might compromise
the pill’s absorption of ionising radiation. During dissolu-
tion into liquefied parts the density decreases, starting in
the periphery and sparing the centre. For practical reasons,
the authors suggest measuring the pills or the remainder
of the pills in the bowel several times, with smaller ROIs
in the centre of the pill and using only the highest mea-
sured attenuation. However, these assumptions must be ad-
dressed in future trials. Our results are only valid for exact-
ly the same medications with the same dosages and from
the same vendor. Generic medications or other concentra-
tions of the medications might demonstrate other attenua-
tions. If this method of substance characterisation proves
useful in the future, pharmaceutical substances could be
labelled with their standard attenuation coefficients and
which could thus serve as an identifier.
Our data suggest that measuring the attenuation of drugs
on CT images, including the homogeneity, and applying
CT spectroscopy can narrow down possible identities of
the most frequent medications. Other clinicians and foren-
sic pathologists can perform this easy measurement, as the
intra- and inter-reader variability is very small.
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